The Food and Drug Administration (FDA) has issued a recall on a third eye drop brand, including one that has been linked to serious infections, vision loss and a death.
Consumers have been advised to stop using the following brands of eye drops and return them to where they were purchased.
- Brimonidine Tartrate Ophthalmic Solution 0.15%. Apotex Corp. initiated the voluntary recall for six lots of Brimonidine Tartrate Ophthalmic Solution on March 1, 2023, due to cracks in the caps. The prescription drops are being used for patients with open-angle glaucoma or ocular hypertension. no infections have been associated with the product.
- Artificial Tears Lubricants Eye Drops distributed by EzriCare, LLC and DELSAM Pharma On Feb. 2, 2023, the FDA issued a warning not to use EzriCare Artificial Tears because of potential bacterial contamination. The over-the-counter product was associated with severe eye infections in 55 patients, including one death. The infections were caused by a drug-resistant bacteria, Pseudomonas aeruginosa.
- Purely Soothing 15% MSM Drops. The FDA announced on March 3, 2023, that Pharmedica USA was voluntarily recalling two lots of Purely Soothing Drops. This over-the-counter product is being recalled due to non-sterility. There have not been reports of illness or infection related to the product.
The FDA has also recalled Global Pharma Healthcare Artificial Eye Ointment in addition to the drops due to possible bacterial infection.
For more on the recalls, click here